Vanguard Group
KANG

Vanguard Group’s iKang Healthcare Group, Inc. KANG Stock Holding History

Vanguard Group’s Portfolio KANG Stock Details KANG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-1,489,363
Closed -$30.4M – 4170
2018
Q4 		$30.4M Buy
1,489,363
+192,923
+15% +$3.43M ﹤0.01% 2257
2018
Q3 		$23.5M Buy
1,296,440
+41,174
+3% +$793K ﹤0.01% 2509
2018
Q2 		$25.7M Buy
1,255,266
+265,497
+27% +$5.35M ﹤0.01% 2457
2018
Q1 		$19.7M Buy
989,769
+679,711
+219% +$11.4M ﹤0.01% 2504
2017
Q4 		$4.9M Buy
310,058
+248,455
+403% +$3.59M ﹤0.01% 3144
2017
Q3 		$831K Buy
61,603
+47,003
+322% +$629K ﹤0.01% 3634
2017
Q2 		$179K Hold
14,600
– – ﹤0.01% 3920
2017
Q1 		$213K Hold
14,600
– – ﹤0.01% 3895
2016
Q4 		$253K Hold
14,600
– – ﹤0.01% 3853
2016
Q3 		$264K Hold
14,600
– – ﹤0.01% 3858
2016
Q2 		$268K Buy
+14,600
New +$294K ﹤0.01% 3897

Vanguard Group's KANG Position: Q1 2019 in Review

Vanguard Group sold out of iKang Healthcare Group, Inc. (KANG) in Q1 2019, closing a stake of 1,489,363 shares — an estimated $30.4M sold.

Vanguard Group first reported a position in KANG in Q2 2016 and held it in 11 quarters. The position peaked at $30.4M in Q4 2018. 0 funds tracked by Wall St. Rank hold KANG as of Q1 2019.

  • Vanguard Group reported no remaining iKang Healthcare Group, Inc. position as of Q1 2019 after selling out during the quarter.
  • Vanguard Group sold 1,489,363 iKang Healthcare Group, Inc. shares in Q1 2019, an estimated $30.4M.
  • Vanguard Group first reported a position in iKang Healthcare Group, Inc. in Q2 2016 and held it in 11 quarters.
  • Vanguard Group's iKang Healthcare Group, Inc. position peaked at $30.4M in Q4 2018.
  • 0 funds tracked by Wall St. Rank held iKang Healthcare Group, Inc. as of Q1 2019.

Based on Vanguard Group's 13F filing for Q1 2019, filed 15 May 2019.